An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified "molecular ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

‘This is my passion. It started out personal to me; it still is, extremely so,' said Dr Cross. Dozens of drugs to slow cognitive decline in dementia over the past decade have failed to show a real ...

UWE Bristol is launching a project aimed at transforming the assessment and diagnosis of dementia for people from three ...

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

Penn Medicine researchers will advance their understanding of the underlying causes of cognitive decline in individuals with Lewy body diseases, like Parkinson's, and identify biomarkers that predict ...

Researchers at the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine have received a $4.7 ...

The way in which brains shrink in those who develop Alzheimer’s disease follows no specific or uniform pattern, finds a new study by researchers at UCL and Radboud University in the Netherlands.

Researchers have developed a molecule called LaKe that mimics the metabolic effects of strenuous exercise and fasting.

According to Alzheimer’s Disease International and Dementia Forecasting Collaborators, Alzheimer’s Disease is currently the ...